Download Cancer Prevention - From Mechs. to Translational Benefits by A. Georgakilas PDF

By A. Georgakilas

Show description

Read Online or Download Cancer Prevention - From Mechs. to Translational Benefits PDF

Similar cancer books

Alternative Healthcare for Dogs Facing Cancer: Apollo's Story

Apollo's Creed & legacy to you is that will help you locate all of the assets & treatment plans attainable on your puppy to aid him/her to cause them to consider higher. And if the time has to come back to claim goodbye. .. you're capable of face that lifestyles occasion with braveness, gratitude to your pet's lifestyles & so much of all ~ no regrets!

Bacteria and Cancer

Bacterial infections reason vast morbidity and mortality in melanoma sufferers. those infections regularly remained enigmatic because of preliminary reluctance of melanoma researchers in figuring out their etiologic power. Etiological organization of micro organism with melanoma won credibility after discovery of carcinogenic power of Helicobacter pylori.

Molecular Pathology of Breast Cancer

The complicated panorama of breast melanoma calls for particular suggestions for the administration of assorted molecular subtypes of this sickness. speedy advances within the box of molecular biology were bewildering for these inquisitive about its learn and administration. “Molecular Pathology of Breast melanoma” goals to shut this data hole by way of discussing comprehensively the evolution, organic foundation and medical functions with a spotlight at the “what, whilst, and the way” of the main major molecular markers identified to this point.

Additional resources for Cancer Prevention - From Mechs. to Translational Benefits

Example text

L. (2008). Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial. Lancet 372, 1756-1764. , and Mohammadi, M. (2009). The FGF family: biology, pathophysiology and therapy. Nat Rev Drug Discov 8, 235-253. E. (2003). Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3, 401-410. , and Hanahan, D. (2008). Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer 8, 592-603. , and Hanahan, D. (2003). Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors.

Nat Rev Drug Discov 3, 391-400. S. (2005). Angiogenesis as a therapeutic target. Nature 438, 967974. J. (1990). Stem cell origin of human myeloid blood cell neoplasms. Verh Dtsch Ges Pathol 74, 43-47. J. (2002). Critical determinants of metastasis. Semin Cancer Biol 12, 89-96. , et al. (2007). Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels. Cell 131, 463-475. Folkman, J. (1971). Tumor angiogenesis: therapeutic implications. N Engl J Med 285, 11821186.

Lang, L. (2008). FDA approves sorafenib for patients with inoperable liver cancer. Gastroenterology 134, 379. E. (1994). A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367, 645-648. , and Richmond, A. (2010). Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol Med 16, 133-144. Lenzer, J. (2011). FDA committee votes to withdraw bevacizumab for breast cancer. BMJ 343, d4244. M. (2007). Identification of pancreatic cancer stem cells.

Download PDF sample

Rated 4.32 of 5 – based on 20 votes